Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Menopause can cause skin issues, and seeing a dermatologist helps.

Finger length ratio may indicate male hair loss.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

The normal human prostate does not significantly affect blood DHT levels.

Certain cells from hair follicles can create new hair and contribute to hair growth when implanted in mice.

New treatments for male hypogonadism are effective and should be personalized.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Some men can have female pattern baldness without hormonal abnormalities or signs of feminization.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Acne in dark skin is influenced by environmental factors and can lead to hyperpigmentation, with various treatment options available.